ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 324 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,320,830 | -9.1% | 163,854 | +4.7% | 0.02% | -10.5% |
| Q1 2024 | $4,752,267 | -0.3% | 156,479 | -7.8% | 0.02% | 0.0% |
| Q4 2023 | $4,766,761 | +14.6% | 169,696 | +10.7% | 0.02% | 0.0% |
| Q3 2023 | $4,161,000 | -20.3% | 153,298 | -9.7% | 0.02% | -9.5% |
| Q2 2023 | $5,219,000 | -23.5% | 169,782 | -10.3% | 0.02% | -25.0% |
| Q1 2023 | $6,821,000 | -11.2% | 189,320 | -2.5% | 0.03% | -15.2% |
| Q4 2022 | $7,677,000 | +0.8% | 194,268 | +2.5% | 0.03% | -2.9% |
| Q3 2022 | $7,618,000 | -2.4% | 189,596 | +2.1% | 0.03% | +3.0% |
| Q2 2022 | $7,808,000 | -15.1% | 185,727 | -21.3% | 0.03% | +3.1% |
| Q1 2022 | $9,200,000 | +31.2% | 236,141 | +34.2% | 0.03% | +33.3% |
| Q4 2021 | $7,011,000 | +6.4% | 175,939 | -3.5% | 0.02% | +4.3% |
| Q3 2021 | $6,588,000 | -13.6% | 182,299 | -2.0% | 0.02% | -14.8% |
| Q2 2021 | $7,627,000 | +1.7% | 186,071 | +8.3% | 0.03% | -10.0% |
| Q1 2021 | $7,496,000 | +180.1% | 171,839 | +221.4% | 0.03% | +150.0% |
| Q4 2020 | $2,676,000 | – | 53,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |